PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and ...

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

UiPath PATH shares are trading higher on Wednesday. The company recently achieved AIUC 1 certification, setting a new standard for AI agent security and reliability. • How is PATH stock doing now?

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

UiPath Inc PATH reported financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. Here’s a look at the key details from the report. UiPath shares are advancing ...

UiPath (NYSE: PATH), a leader in agentic automation, announced today the Company has rescheduled its fourth quarter ...

UiPath Inc. reports fiscal fourth-quarter results Wednesday after market close, with investors scrutinizing whether the automation software maker’s pivot to artificial intelligence-powered "agentic ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath stock sinks despite reporting its first-ever profit in Q4. A new buyback plan is failing to support PATH share price as well. Here's why the price action on Thursday does make sense.

UiPath (PATH) stock slides after Q4 FY26 results as Needham upgrades to Buy on ARR and free cash flow growth; AI ARR hits $200M.

UiPath (NYSE: PATH) is on the path to a full market reversal because its March price pullback is an irrational response to good news. The company's Q4 fiscal year 2026 (FY2026) results topped ...